Corrigendum

Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130)

Yu Tang Chin, Zong Rong He, Chi Long Chen, Hsiao Ching Chu, Yih Ho, Po Yu Su, Yu Chen S.H. Yang, Kuan Wang, Ya Jung Shih, Yi Ru Chen, Jens Z. Pedersen, Sandra Incerpi, André Wendindondé Nana, Heng Yuan Tang, Hung Yun Lin, Shaker A. Mousa, Paul J. Davis, Jacqueline Whang-Peng

Research output: Contribution to journal › Comment/debate

1 Citation (Scopus)

Abstract

In the original article, we neglected to include the funder “E-Da Hospital, EDAHP107018” to Z-RH. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Original languageEnglish
Article number241
JournalFrontiers in Endocrinology
Volume10
Issue numberAPR
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Endocrinology
Integrins
Colorectal Neoplasms
corrigendum
tetraiodothyroacetic acid

Keywords

  • Anticancer
  • Colorectal cancer cells
  • Integrin αvβ3
  • NDAT
  • Perfusion bellows cell culture system
  • PhosphoERK1/2
  • Tetrac

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Corrigendum : Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130). / Chin, Yu Tang; He, Zong Rong; Chen, Chi Long; Chu, Hsiao Ching; Ho, Yih; Su, Po Yu; Yang, Yu Chen S.H.; Wang, Kuan; Shih, Ya Jung; Chen, Yi Ru; Pedersen, Jens Z.; Incerpi, Sandra; Nana, André Wendindondé; Tang, Heng Yuan; Lin, Hung Yun; Mousa, Shaker A.; Davis, Paul J.; Whang-Peng, Jacqueline.

In: Frontiers in Endocrinology, Vol. 10, No. APR, 241, 01.01.2019.

Research output: Contribution to journal › Comment/debate

Chin, YT, He, ZR, Chen, CL, Chu, HC, Ho, Y, Su, PY, Yang, YCSH, Wang, K, Shih, YJ, Chen, YR, Pedersen, JZ, Incerpi, S, Nana, AW, Tang, HY, Lin, HY, Mousa, SA, Davis, PJ & Whang-Peng, J 2019, 'Corrigendum: Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130)', Frontiers in Endocrinology, vol. 10, no. APR, 241. https://doi.org/10.3389/fendo.2019.00241
Chin YT, He ZR, Chen CL, Chu HC, Ho Y, Su PY et al. Corrigendum: Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130). Frontiers in Endocrinology. 2019 Jan 1;10(APR). 241. https://doi.org/10.3389/fendo.2019.00241
Chin, Yu Tang ; He, Zong Rong ; Chen, Chi Long ; Chu, Hsiao Ching ; Ho, Yih ; Su, Po Yu ; Yang, Yu Chen S.H. ; Wang, Kuan ; Shih, Ya Jung ; Chen, Yi Ru ; Pedersen, Jens Z. ; Incerpi, Sandra ; Nana, André Wendindondé ; Tang, Heng Yuan ; Lin, Hung Yun ; Mousa, Shaker A. ; Davis, Paul J. ; Whang-Peng, Jacqueline. / Corrigendum : Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130). In: Frontiers in Endocrinology. 2019 ; Vol. 10, No. APR.
@article{44accd234e2e48639f0a5782ffd478fb,
title = "Corrigendum: Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130)",
abstract = "In the original article, we neglected to include the funder “E-Da Hospital, EDAHP107018” to Z-RH. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.",
keywords = "Anticancer, Colorectal cancer cells, Integrin αvβ3, NDAT, Perfusion bellows cell culture system, PhosphoERK1/2, Tetrac",
author = "Chin, {Yu Tang} and He, {Zong Rong} and Chen, {Chi Long} and Chu, {Hsiao Ching} and Yih Ho and Su, {Po Yu} and Yang, {Yu Chen S.H.} and Kuan Wang and Shih, {Ya Jung} and Chen, {Yi Ru} and Pedersen, {Jens Z.} and Sandra Incerpi and Nana, {Andr{\'e} Wendindond{\'e}} and Tang, {Heng Yuan} and Lin, {Hung Yun} and Mousa, {Shaker A.} and Davis, {Paul J.} and Jacqueline Whang-Peng",
year = "2019",
month = "1",
day = "1",
doi = "10.3389/fendo.2019.00241",
language = "English",
volume = "10",
journal = "Frontiers in Endocrinology",
issn = "1664-2392",
publisher = "Frontiers Media S. A.",
number = "APR",

}

TY - JOUR

T1 - Corrigendum

T2 - Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130)

AU - Chin, Yu Tang

AU - He, Zong Rong

AU - Chen, Chi Long

AU - Chu, Hsiao Ching

AU - Ho, Yih

AU - Su, Po Yu

AU - Yang, Yu Chen S.H.

AU - Wang, Kuan

AU - Shih, Ya Jung

AU - Chen, Yi Ru

AU - Pedersen, Jens Z.

AU - Incerpi, Sandra

AU - Nana, André Wendindondé

AU - Tang, Heng Yuan

AU - Lin, Hung Yun

AU - Mousa, Shaker A.

AU - Davis, Paul J.

AU - Whang-Peng, Jacqueline

PY - 2019/1/1

Y1 - 2019/1/1

N2 - In the original article, we neglected to include the funder “E-Da Hospital, EDAHP107018” to Z-RH. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

AB - In the original article, we neglected to include the funder “E-Da Hospital, EDAHP107018” to Z-RH. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

KW - Anticancer

KW - Colorectal cancer cells

KW - Integrin αvβ3

KW - NDAT

KW - Perfusion bellows cell culture system

KW - PhosphoERK1/2

KW - Tetrac

UR - http://www.scopus.com/inward/record.url?scp=85067693595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067693595&partnerID=8YFLogxK

U2 - 10.3389/fendo.2019.00241

DO - 10.3389/fendo.2019.00241

M3 - Comment/debate

VL - 10

JO - Frontiers in Endocrinology

JF - Frontiers in Endocrinology

SN - 1664-2392

IS - APR

M1 - 241

ER -

Access to Document